# TRILYTE
> **ANDA076491** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 2004-02-05
## Drug
- **FDA Application Number:** ANDA076491
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRILYTE
- **Generic name:** POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE
- **Active ingredients:** POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA USA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2004-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076491)
---
*AI Analytics · CC0 1.0*